Evidence map›Paper›PMID 41040173›Full record

ArticlebioRxiv : the preprint server for biology2025

Behavioral Decoding Reveals Cortical Endocannabinoid Potentiation during Δ

Anthony English, David Marcus, Khushi Yadav, Yassin Elkhouly, Allan Levy, Victoria Corbit, Maddie Ask, Anika Scedberg, Jordan Poces-Ball, Fleur Uittenbogaard and 6 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Anthony EnglishDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
David MarcusDepartment of Anesthesiology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Khushi YadavDepartment of Anesthesiology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Yassin ElkhoulyDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Allan LevyDepartment of Anesthesiology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Victoria CorbitPrinceton Neuroscience Institute, Princeton University, Princeton, NJ, USA.
Maddie AskDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Anika ScedbergDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Jordan Poces-BallDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Fleur UittenbogaardDepartment of Anesthesiology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Rayna SimonsDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Ilana WittenPrinceton Neuroscience Institute, Princeton University, Princeton, NJ, USA.
Larry ZweifelDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Benjamin LandDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Nephi StellaDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Michael R BruchasDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.

Funding

DISSECTING DYNORPHIN-KAPPA OPIOID MEDIATED REINSTATEMENT OF NICOTINE PREFERENCER37DA033396 · NIDA · WASHINGTON UNIVERSITY · PI Michael R. Bruchas · 2018 to 2026
$3.8M
Cannabidiol and terpenoid interactions in amygdalar regulation of pain statesR01AT011524 · NCCIH · UNIVERSITY OF WASHINGTON · PI Benjamin Land · 2022 to 2026
$2.1M
DISSECTING DYNORPHIN-KAPPA OPIOID MEDIATED REINSTATEMENT OF NICOTINE PREFERENCER01DA033396 · NIDA · WASHINGTON UNIVERSITY · PI BRUCHAS, MICHAEL R. · 2013 to 2017
$1.9M
Impact on adult mouse brain of oral THC and CBD consumption during adolescenceR21DA051558 · NIDA · UNIVERSITY OF WASHINGTON · PI STELLA, NEPHI · 2020 to 2021
$428k
Differential control of 2-AG’s activity at CB1R by ABHD6 and MAGLR21DA056816 · NIDA · UNIVERSITY OF WASHINGTON · PI STELLA, NEPHI · 2023 to 2024
$428k
Role of CB1R expressed in the prefrontal cortex in the control of locomotionR21DA057186 · NIDA · UNIVERSITY OF WASHINGTON · PI STELLA, NEPHI · 2023 to 2024
$428k
Dissecting PFC Endocannabinoid-THC -regulated circuits in movement behaviorF31DA055448 · NIDA · UNIVERSITY OF WASHINGTON · PI ENGLISH, ANTHONY EDWARD · 2022 to 2024
$131k
NCCIH NIH HHS R01 AT011524NIDA NIH HHS F31 DA055448NIDA NIH HHS R01 DA033396NIDA NIH HHS R21 DA051558NIDA NIH HHS R21 DA056816NIDA NIH HHS R21 DA057186NIDA NIH HHS R37 DA033396
6 · The paper itself

Abstract

How Δ

Identifiers

PMID41040173
PMCPMC12485844

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.